Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalnex Solutio. Regulatory News (CLX)

Share Price Information for Calnex Solutio. (CLX)

Share Price is delayed by 15 minutes
Get Live Data
58.50    0.00 (0.00%)
Bid:
58.00
Ask:
59.00
Spread: 1.00 (1.724%)
Market Cap: £51.52m
CLX Live PriceLast checked at - London Stock Exchange

Intraday Calnex Solutio. Share Chart

Share Options

1 Nov 2006 07:00

Calyx Group PLC01 November 2006 FOR IMMEDIATE RELEASE 1 November 2006 Calyx plc ("the Company") Grant of share options Calyx Group plc, one of the largest single source providers of Networked ITServices in both the United Kingdom and Ireland, today announces that theCompany has granted share options to Directors and staff. The options will beexercisable at 90 pence (€0.60) per Ordinary Share. Shares Total share Beneficial Resultant Resultant options Interest Beneficial Beneficial granted on 1 options held prior to Interest interest as November 2006 on the grant (assuming a per centDirector of the all options of the 1 November share exercised) enlarged 2006 options issued share capital No. No. No. No. % Maurice Healy 500,000 500,000 19,833,075 20,333,375 28.31Peter Jenkins 300,000 300,000 - 300,000 0.42Ger Coakley 102,750 250,000 817,939 1,067,939 1.49Judith O'Brien 52,750 200,000 817,939 1,017,939 1.42Other Staff 2,350,800 3,193,000 n/a n/a n/a Notes 1. The options were granted for nominal consideration; 2. All Board Directors and other senior executives' new options will have aperformance condition; all other options will not have a performance condition; 4. The Company currently has 67,369,315 Ordinary Shares in issue; 5. The Company now has 4,443,000 share options outstanding, representing 6.6% ofthe current issued Ordinary Share capital or 6.2% of the enlarged issuedOrdinary Share capital 6. All the options will have vesting periods which are the same as the Company'sexisting options i.e. 50% vest after 2 years and the other 50% vest after 3years. For further information, please contact Calyx Group plcMaurice Healy, Chief Executive +353 1 883 5509Peter Jenkins, CFO +353 1 883 5509 Buchanan CommunicationsTim Thompson/James Strong +44(0)20 7466 5000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th May 20239:00 amRNSPDMR Dealings
4th May 20237:00 amRNSNotice of Results and Investor Presentation
14th Apr 20236:03 pmRNSPDMR Dealings
14th Apr 20233:24 pmRNSDirector Dealing
15th Mar 20231:15 pmRNSDirector Dealings
14th Mar 20234:00 pmRNSPDMR Dealings
7th Mar 20239:05 amRNSSecond Price Monitoring Extn
7th Mar 20239:00 amRNSPrice Monitoring Extension
7th Mar 20237:00 amRNSTrading Update
15th Feb 202310:59 amRNSPDMR Dealings
19th Jan 20239:56 amRNSPDMR Dealings
17th Jan 20239:56 amRNSDirector / PDMR Dealings
17th Jan 20239:52 amRNSHolding(s) in Company
17th Jan 20237:00 amRNSBoard Changes
13th Jan 20234:00 pmRNSDirector/PDMR Dealing
13th Dec 20222:15 pmRNSDirector / PDMR Dealings
22nd Nov 20227:00 amRNSInterim Results
21st Nov 20225:43 pmRNSDirector / PDMR Dealings
27th Oct 20227:00 amRNSNotice of Results and Investor Presentation
14th Oct 20223:53 pmRNSDirector/PDMR Shareholding
12th Oct 20221:29 pmRNSDirector / PDMR Dealings
15th Sep 20227:30 amRNSDirector/PDMR Dealing
17th Aug 20225:26 pmRNSResult of AGM
17th Aug 20227:00 amRNSAGM Statement
15th Aug 202210:26 amRNSDirector / PDMR Dealings
26th Jul 20223:33 pmRNSDirector / PDMR Shareholding
18th Jul 20227:00 amRNSNotice of AGM
14th Jul 20225:49 pmRNSDirector/PDMR Dealings
8th Jul 20226:01 pmRNSDirector / PDMR dealings
15th Jun 20227:00 amRNSExercise of Options
14th Jun 20227:00 amRNSBoard Update
6th Jun 20221:30 pmRNSDirector Dealing
24th May 20227:00 amRNSFY22 Final Results
6th May 20227:00 amRNSNotice of Investor Presentation
26th Apr 20229:13 amRNSAward of Options
22nd Apr 202210:50 amRNSHolding(s) in Company
21st Apr 20223:37 pmRNSPDMR Dealing
21st Apr 20227:00 amRNSCalnex receives two Queen’s awards for Enterprise
12th Apr 20227:00 amRNSAcquisition of iTrinegy and Update on Trading
1st Mar 20227:00 amRNSTrading Update
25th Jan 202210:00 amRNSDirector Dealing
11th Jan 20227:00 amRNSBoard Appointments
29th Nov 20212:00 pmRNSPrice Monitoring Extension
26th Nov 20219:55 amRNSHolding(s) in Company
23rd Nov 20214:41 pmRNSSecond Price Monitoring Extn
23rd Nov 20214:35 pmRNSPrice Monitoring Extension
23rd Nov 20212:06 pmRNSSecond Price Monitoring Extn
23rd Nov 20212:00 pmRNSPrice Monitoring Extension
23rd Nov 20217:00 amRNSInterim Results
10th Nov 20217:00 amRNSNotice of Results and Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.